About Erlotinib 150 mg Tablet
Introducing the New Erlotinib 150 mg Tablet, an elite, top-rated solution specifically formulated for the monumental battle against non-small cell lung cancer and pancreatic cancer. This wondrous antineoplastic agent, with a kingly blend of Erlotinib Hydrochloride, epitomizes modern targeted therapy. Each film-coated, white to off-white tablet ensures patient comfort and compliance. Packaged in boxes of 30 tablets, each dose delivers unwavering efficacy under Rx supervision. Manufactured to exact specifications for adults, this product stands as a monumental advancerelying on global distribution networks from Indias premier dealer, distributor, and supplier.
Erlotinib 150 mg Tablet: Site of Application and Uses
Erlotinib 150 mg Tablet is designed for oral administration, directly targeting cancer cells within the body. Used predominantly in the treatment of non-small cell lung cancer and pancreatic cancer, this tablet provides a precision-oriented therapy. Suitable exclusively for adult patients, it offers a targeted approach to inhibit tumor growth. Its formulation enables easy swallowing, making it convenient and practical for those undergoing intensive cancer treatment regimens.
Payment Terms, Sample Availability, and Shipping Information for Erlotinib 150 mg Tablet
Erlotinib 150 mg Tablet is supplied under flexible payment terms to accommodate our clients, with samples available for quality assurance upon request. The goods are transported safely and securely from our domestic manufacturing base to major markets, utilizing reliable freight carriers. Shipments are dispatched from designated FOB ports in India, ensuring efficient supply and distribution. All products arrive meticulously packaged, ensuring the integrity of the medication during every stage of the domestic and international mar.
FAQs of Erlotinib 150 mg Tablet:
Q: How should Erlotinib 150 mg Tablet be administered?
A: Erlotinib 150 mg Tablet should be taken orally, exactly as prescribed by your oncologist, typically once daily on an empty stomach, at least one hour before or two hours after eating.
Q: What is the primary use of Erlotinib 150 mg Tablet?
A: This tablet is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer in adult patients, acting as a targeted tyrosine kinase inhibitor.
Q: When is it appropriate to begin treatment with Erlotinib 150 mg Tablet?
A: Treatment with Erlotinib should begin only upon prescription and under the supervision of an oncologist experienced in managing cancer therapies.
Q: Where should Erlotinib 150 mg Tablets be stored?
A: Store Erlotinib Tablets below 30C, protected from moisture and direct sunlight, to preserve their efficacy and stability throughout the 24-month shelf life.
Q: What are the benefits of using a film-coated Erlotinib 150 mg Tablet?
A: The film-coated nature of the tablet enhances swallowing comfort and helps ensure consistent delivery of the active ingredient, supporting adherence to therapy.
Q: What process should a buyer follow to acquire Erlotinib 150 mg Tablets for distribution?
A: Interested dealers or suppliers should contact the authorized exporter in India, confirm payment terms, and facilitate transport via FOB port with the required documentation and prescription details.